1. Home
  2. VINP vs MRVI Comparison

VINP vs MRVI Comparison

Compare VINP & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vinci Partners Investments Ltd.

VINP

Vinci Partners Investments Ltd.

N/A

Current Price

$9.54

Market Cap

662.7M

Sector

Finance

ML Signal

N/A

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

N/A

Current Price

$5.06

Market Cap

559.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VINP
MRVI
Founded
2009
2014
Country
Brazil
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
662.7M
559.0M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
VINP
MRVI
Price
$9.54
$5.06
Analyst Decision
Strong Buy
Buy
Analyst Count
2
4
Target Price
$14.00
$4.13
AVG Volume (30 Days)
68.0K
2.7M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
5.72%
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
$18.07
$12.54
Revenue Next Year
$12.74
$7.87
P/E Ratio
$24.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.20
$1.99
52 Week High
$13.61
$5.21

Technical Indicators

Market Signals
Indicator
VINP
MRVI
Relative Strength Index (RSI) 31.85 71.47
Support Level N/A $3.27
Resistance Level $10.24 N/A
Average True Range (ATR) 0.31 0.24
MACD -0.05 0.03
Stochastic Oscillator 9.59 86.78

Price Performance

Historical Comparison
VINP
MRVI

About VINP Vinci Partners Investments Ltd.

Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: